Lymphoid leukemia. Lymphoid leukemia
Conditions
Interventions
Intervention 1: Intervention group: Half of the patients will be randomly assigned to receive olanzapine (children aged 7 to 12 will get a dose of 2.5 mg, and those over 12 will get 5 mg every night)
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 16 Years
Inclusion criteria
Inclusion criteria: Children aged 7 to 16 with a cancer diagnosis who are receiving chemotherapy and have an ASA I-II score Anxiety state score based on Spence scale with 60 points
Exclusion criteria
Exclusion criteria: History of congenital heart disease Intellectual disability, The use of psychiatric medications, History of liver disorders, History of seizures and neurological conflicts following cancer
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Reducing anxiety from chemotherapy. Timepoint: During chemotherapy treatment. Method of measurement: Visual analogue scale.;Tolerance level and the occurrence of side effects. Timepoint: Study duration. Method of measurement: History taking. | — |
Primary
| Measure | Time frame |
|---|---|
| Reducing anxiety in children with cancer. Timepoint: During chemotherapy treatment. Method of measurement: Spence Children's Anxiety Scale - Child (SCAS-Child). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMonireh Ghazaeian
Mazandaran University of Medical Sciences
Outcome results
None listed